Thuret et al developed nomogram for predicting cancer-specific mortality (CSM) for a patient with penile cancer. This can help to identify a patient who may benefit from more aggressive management. The authors are from the multiple universities in North America and Europe.
Patient selection: male with penile carcinoma
Parameters:
(1) T stage
(2) N stage
(3) tumor histologic grade
|
Parameter |
Finding |
Points |
|
T stage |
T1 |
0 |
|
|
T2 |
17 |
|
|
T3 |
48 |
|
N stage |
pN0 |
0 |
|
|
cN0 |
45 |
|
|
pN1 |
75 |
|
|
pN2 |
88 |
|
|
cN+ |
93 |
|
|
pN3 |
100 |
|
tumor grade |
Grade I |
0 |
|
|
Grade II |
14 |
|
|
Grade III |
27 |
total score =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: 0
• maximum score:175
• The higher the score the worse the 5 years cancer-specific mortality (and the lower the "CSM-free rate").
|
Total Score |
5 Year "Cancer Specific Mortality-Free Rate" (Cancer-Specific Survival) |
|
< 28 |
> 94% |
|
28 to 175 |
(-0.002569 * ((points)^2)) + (0.1087 * (points)) + 92.64 |
|
175 |
30% |
Specialty: Hematology Oncology, Surgery, general, Urology
ICD-10: ,
